GACAT3

gene
On this page

Also known as lncRNA-AC130710

Summary

GACAT3 (gastric cancer associated transcript 3, HGNC:50847) is a long non-coding RNA gene on chromosome 2p24.3.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:50847
Approved symbolGACAT3
Namegastric cancer associated transcript 3
Location2p24.3
Locus typeRNA, long non-coding
StatusApproved
AliaseslncRNA-AC130710
Ensembl geneENSG00000236289
Ensembl biotypelncRNA
OMIM616132
Entrez104797537
RNAcentralURS00007E409E — lncRNA, 984 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 21 — 21 lncRNA

ENST00000426539, ENST00000442387, ENST00000651705, ENST00000651908, ENST00000651993, ENST00000652394, ENST00000652731, ENST00000667080, ENST00000777279, ENST00000777280, ENST00000777281, ENST00000777282, ENST00000777283, ENST00000777284, ENST00000777285, ENST00000777286, ENST00000777287, ENST00000777288, ENST00000777289, ENST00000777290, ENST00000777291

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000426539 — 4 exons

ExonStartEnd
ENSE000016035031605042716050677
ENSE000016411591608528916085801
ENSE000017069211607330416073442
ENSE000017992521608089816081090

Expression profiles

Bgee: expression breadth broad, 92 present calls, max score 96.28.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0835 / max 16.1639, expressed in 19 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
190180.083519

Top tissues by expression

97 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cerebellar vermisUBERON:000472096.28gold quality
quadriceps femorisUBERON:000137794.46gold quality
thymusUBERON:000237075.49silver quality
bone marrowUBERON:000237174.12silver quality
skeletal muscle tissueUBERON:000113471.94silver quality
spinal cordUBERON:000224062.25gold quality
C1 segment of cervical spinal cordUBERON:000646962.22gold quality
ganglionic eminenceUBERON:000402360.56gold quality
ventricular zoneUBERON:000305359.46silver quality
primary visual cortexUBERON:000243658.58gold quality
sural nerveUBERON:001548857.22silver quality
substantia nigraUBERON:000203857.03gold quality
prefrontal cortexUBERON:000045156.85gold quality
right adrenal gland cortexUBERON:003582755.88gold quality
spleenUBERON:000210654.01gold quality
heart left ventricleUBERON:000208453.78gold quality
monocyteCL:000057653.13gold quality
urinary bladderUBERON:000125553.03silver quality
right adrenal glandUBERON:000123352.79gold quality
frontal cortexUBERON:000187051.48gold quality
adrenal tissueUBERON:001830351.18gold quality
minor salivary glandUBERON:000183051.13gold quality
liverUBERON:000210750.82silver quality
Ammon’s hornUBERON:000195450.65gold quality
bloodUBERON:000017850.64gold quality
left ovaryUBERON:000211950.50gold quality
adrenal glandUBERON:000236950.45gold quality
ovaryUBERON:000099250.35gold quality
superior frontal gyrusUBERON:000266149.87gold quality
left adrenal gland cortexUBERON:003582549.74gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.61

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 9)

  • lncRNA-AC130710 may be a potential tumor marker for gastric cancer prognosis (PMID:24969565)
  • Studies suggest that GACAT2 (long noncoding RNA HMlincRNA717) and GACAT3 (long noncoding RNA AC130710) may play crucial roles in the occurrence, development and diagnosis of gastric carcinoma. (PMID:25077925)
  • as a downstream target of the IL6/STAT3 signaling, Long non-coding RNA GACAT3 promotes gastric cancer cell growth suggesting that GACAT3 is an inflammatory response gene and may be served as a valuable potential target for the treatment of gastric cancer. (PMID:27644247)
  • GACAT3 promotes breast cancer malignancy by sponging miR-497, leading to the enhancement of its endogenous target CCND2. These results suggest that GACAT3/miR-497/CCND2 is a potential therapeutic target and biomarker for breast cancer (PMID:29945347)
  • Study demonstrate that GACAT3 acts as a competing endogenous RNA of HMGA1. Its knockdown resulted in significantly decreased cell proliferation of gastric cancer cells, similar to the effect of an HMGA1 knockdown. (PMID:30098426)
  • This study elucidated that GACAT3/miR-3127-5p/ELAVL1 signaling regulates glioma development and might be a promising therapeutic target. (PMID:30317610)
  • Long noncoding RNA GACAT3 regulates the expression of NAMPT to promote glioma progression by sponging miR-135a. (PMID:30536379)
  • High LncRNA-GACAT3 expression is associated with breast cancer. (PMID:31983109)
  • LncRNAs GACAT3 and LINC00152 regulate each other through miR-103 and are associated with clinicopathological characteristics in colorectal cancer. (PMID:32462718)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.